% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{MartinezHernandez:139722,
author = {Martinez Hernandez, Ana and Urbanke, Hendrik and Gillman,
Alan L and Lee, Joon and Ryazanov, Sergey and Agbemenyah,
Hope Y and Benito, Eva and Jain, Gaurav and Kaurani, Lalit
and Grigorian, Gayane and Leonov, Andrei and Rezaei-Ghaleh,
Nasrollah and Wilken, Petra and Arce, Fernando Teran and
Wagner, Jens and Fuhrmann, Martin and Caruana, Mario and
Camilleri, Angelique and Vassallo, Neville and Zweckstetter,
Markus and Benz, Roland and Giese, Armin and Schneider, Anja
and Korte, Martin and Lal, Ratnesh and Griesinger, Christian
and Eichele, Gregor and Fischer, Andre},
title = {{T}he diphenylpyrazole compound anle138b blocks {A}β
channels and rescues disease phenotypes in a mouse model for
amyloid pathology.},
journal = {EMBO molecular medicine},
volume = {10},
number = {1},
issn = {1757-4676},
address = {Heidelberg},
publisher = {EMBO Press},
reportid = {DZNE-2020-06044},
pages = {32-47},
year = {2018},
abstract = {Alzheimer's disease is a devastating neurodegenerative
disease eventually leading to dementia. An effective
treatment does not yet exist. Here we show that oral
application of the compound anle138b restores hippocampal
synaptic and transcriptional plasticity as well as spatial
memory in a mouse model for Alzheimer's disease, when given
orally before or after the onset of pathology. At the
mechanistic level, we provide evidence that anle138b blocks
the activity of conducting Aβ pores without changing the
membrane embedded Aβ-oligomer structure. In conclusion, our
data suggest that anle138b is a novel and promising compound
to treat AD-related pathology that should be investigated
further.},
keywords = {Alzheimer Disease: drug therapy / Alzheimer Disease:
genetics / Alzheimer Disease: metabolism / Alzheimer
Disease: physiopathology / Amyloid beta-Peptides: genetics /
Amyloid beta-Peptides: metabolism / Animals / Benzodioxoles:
pharmacology / Benzodioxoles: therapeutic use / Disease
Models, Animal / Hippocampus: drug effects / Hippocampus:
metabolism / Hippocampus: physiopathology / Male / Mice /
Mice, Inbred C57BL / Neuronal Plasticity: drug effects /
Phenotype / Pyrazoles: pharmacology / Pyrazoles: therapeutic
use / Spatial Memory: drug effects / Transcriptome: drug
effects /
3-(1,3-benzodioxol-5-yl)-5-(3-bromophenyl)-1H-pyrazole (NLM
Chemicals) / Amyloid beta-Peptides (NLM Chemicals) /
Benzodioxoles (NLM Chemicals) / Pyrazoles (NLM Chemicals)},
cin = {AG Fischer ; AG Fischer / AG Zweckstetter / AG Fuhrmann /
AG Schneider Göttingen},
ddc = {610},
cid = {I:(DE-2719)1410002 / I:(DE-2719)1410001 /
I:(DE-2719)1011004 / I:(DE-2719)1440011},
pnm = {342 - Disease Mechanisms and Model Systems (POF3-342) / 344
- Clinical and Health Care Research (POF3-344)},
pid = {G:(DE-HGF)POF3-342 / G:(DE-HGF)POF3-344},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:29208638},
pmc = {pmc:PMC5760857},
doi = {10.15252/emmm.201707825},
url = {https://pub.dzne.de/record/139722},
}